Microfluidic Immunoassay Market to be Worth $1.47 Billion by 2030

Meticulous Research®, a prominent global market research firm, has published a report titled "Microfluidic Immunoassay Market Size, Share, Forecast, & Trends Analysis by Product (Cartridge [Polymer, Glass], Reagent, System) Technology (Electrochemical, Optical) Application (Cardiology, Oncology, Infectious Disease) End User—Global Forecast to 2031."
According to the latest findings from Meticulous Research®, the global market for microfluidic immunoassays is projected to reach $1.59 billion by 2031,, expanding at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031. This growth is driven by increasing applications of microfluidic immunoassays in drug discovery, biomarker detection, and the advantages they offer over traditional methods. Factors contributing to this growth include heightened research and development activities in pharmaceutical and biotechnology sectors, as well as a trend towards miniaturizing biological and chemical assays. Challenges such as issues with bubble formation and dead volume in microfluidic devices are identified as potential barriers to market expansion.
Moreover, the rising demand for point-of-care diagnostics and recent technological advancements in microfluidic immunoassay systems are expected to generate new opportunities for market growth. Nevertheless, stakeholders face significant challenges related to selecting suitable substrate materials for designing microfluidic chips, along with constraints in product design and costs particularly in developing nations.

Microfluidic Immunoassay Market to be Worth $1.47 Billion by 2030

Meticulous Research®, a prominent global market research firm, has published a report titled "Microfluidic Immunoassay Market Size, Share, Forecast, & Trends Analysis by Product (Cartridge [Polymer, Glass], Reagent, System) Technology (Electrochemical, Optical) Application (Cardiology, Oncology, Infectious Disease) End User—Global Forecast to 2031."
According to the latest findings from Meticulous Research®, the global market for microfluidic immunoassays is projected to reach $1.59 billion by 2031,, expanding at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2031. This growth is driven by increasing applications of microfluidic immunoassays in drug discovery, biomarker detection, and the advantages they offer over traditional methods. Factors contributing to this growth include heightened research and development activities in pharmaceutical and biotechnology sectors, as well as a trend towards miniaturizing biological and chemical assays. Challenges such as issues with bubble formation and dead volume in microfluidic devices are identified as potential barriers to market expansion.
Moreover, the rising demand for point-of-care diagnostics and recent technological advancements in microfluidic immunoassay systems are expected to generate new opportunities for market growth. Nevertheless, stakeholders face significant challenges related to selecting suitable substrate materials for designing microfluidic chips, along with constraints in product design and costs particularly in developing nations.